{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:38:53Z","timestamp":1792791533282,"version":"4.5.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T00:00:00Z","timestamp":1627862400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.biopha.2021.112008","type":"journal-article","created":{"date-parts":[[2021,8,9]],"date-time":"2021-08-09T19:56:32Z","timestamp":1628538992000},"page":"112008","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Repurposing of nifedipine loaded in situ ophthalmic gel as a novel approach for glaucoma treatment"],"prefix":"10.1016","volume":"142","author":[{"given":"Yasmin A.","family":"El-Feky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Roshdy","family":"Fares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal","family":"Zayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania Farag A.","family":"El-Telbany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kawkab A.","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalia Farag A.","family":"El-Telbany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.biopha.2021.112008_bib1","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1080\/10717544.2017.1410262","article-title":"Penetration enhancer-containing spanlastics (PECSs) for transdermal delivery of haloperidol: in vitro characterization, ex vivo permeation and in vivo biodistribution studies","volume":"25","author":"Fahmy","year":"2018","journal-title":"Drug Deliv."},{"issue":"6","key":"10.1016\/j.biopha.2021.112008_bib2","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1007\/s00417-015-3001-7","article-title":"The effect of nifedipine on retinal venous pressure of glaucoma patients with the Flammer-syndrome","volume":"253","author":"Fang","year":"2015","journal-title":"Graefes Arch. Clin. Exp. Ophthalmol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112008_bib3","first-page":"121","article-title":"Design and formulation of twice daily nifedipine sustained release tablet using methocel K15M CR and methocel K100LV CR","volume":"4","author":"Akhter","year":"2012","journal-title":"Int J. Pharm. Pharm. Sci."},{"issue":"1","key":"10.1016\/j.biopha.2021.112008_bib4","first-page":"213","article-title":"Optimization of an ocular nanosuspension formulation for acyclovir using factorial design","volume":"5","author":"El-feky","year":"2013","journal-title":"Int J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.biopha.2021.112008_bib5","doi-asserted-by":"crossref","unstructured":"Y. Pakzad, M. Fathi, Y. Omidi, A. Zamanian, Nanoengineered Biomaterials for Advanced Drug Delivery, Masoud Mozafari, (Ed.), 2020. \u3008https:\/\/doi.org\/10.1016\/c2018-0-02205-7\u3009.","DOI":"10.1016\/C2018-0-02205-7"},{"issue":"1","key":"10.1016\/j.biopha.2021.112008_bib6","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1089\/jop.1994.10.47","article-title":"In situ-forming gels for ophthalmic drug delivery","volume":"10","author":"Kumar","year":"1994","journal-title":"J. Ocul. Pharmacol."},{"key":"10.1016\/j.biopha.2021.112008_bib7","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ijbiomac.2020.02.097","article-title":"Polysaccharide as renewable responsive biopolymer for in situ gel in the delivery of drug through ocular route","volume":"150","author":"Chowhan","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112008_bib8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1517\/17425247.2012.665367","article-title":"In situ gel systems as \u201csmart\u201d carriers for sustained ocular drug delivery","volume":"9","author":"Agrawal","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.biopha.2021.112008_bib9","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ijbiomac.2019.02.094","article-title":"Breaking the barricade of oral chemotherapy through polysaccharide nanocarrier","volume":"130","author":"Dey","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.biopha.2021.112008_bib10","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0939-6411(02)00078-4","article-title":"Development and characterization of buccoadhesive nifedipine tablets","volume":"54","author":"Varshosaz","year":"2002","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.biopha.2021.112008_bib11","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1208\/s12249-009-9230-5","article-title":"Optimization of hydrogels for transdermal delivery of lisinopril by box\u2013behnken statistical design","volume":"10","author":"Gannu","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.biopha.2021.112008_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.120010","article-title":"Development and evaluation of doxycycline niosomalthermoresponsive in situ gel for ophthalmic delivery","volume":"591","author":"Gugleva","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"3","key":"10.1016\/j.biopha.2021.112008_bib13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.2174\/156720110791560928","article-title":"Design and development of thermoreversible ophthalmic in situ hydrogel of moxifloxacin HCl","volume":"7","author":"Shastri","year":"2010","journal-title":"Curr. Drug Deliv."},{"issue":"3","key":"10.1016\/j.biopha.2021.112008_bib14","first-page":"673","article-title":"Formulation and evaluation of nifedipine multiple emulsions","volume":"4","author":"Neeraja","year":"2014","journal-title":"Int. J. Pharm. Chem. Biol. Sci."},{"issue":"6","key":"10.1016\/j.biopha.2021.112008_bib15","first-page":"699","article-title":"Formulation and evaluation of in-situ gel of bromhexine hydrochloride for nasal delivery","volume":"3","author":"Kumar","year":"2012","journal-title":"Der Pharm. Sin."},{"key":"10.1016\/j.biopha.2021.112008_bib16","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ijpharm.2018.11.016","article-title":"Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: in vitro, ex vivo, in vivo and human studies","volume":"554","author":"Ranch","year":"2019","journal-title":"Int. J. Pharm."},{"issue":"578","key":"10.1016\/j.biopha.2021.112008_bib17","article-title":"Comparison of thermosensitive in situ gels and drug-resin complex for ocular drug delivery: in vitro drug release and in vivo tissue distribution","volume":"30","author":"Wei","year":"2020","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.biopha.2021.112008_bib18","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejpb.2017.01.008","article-title":"Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: design, characterisation, toxicity and transcorneal permeation studies","volume":"114","author":"Fathalla","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.112008_bib19","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ijpharm.2016.04.021","article-title":"Ketoroloac tromethamine loaded nanodispersion incorporated into thermosensitive in situ gel for prolonged ocular delivery","volume":"506","author":"Morsi","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"7","key":"10.1016\/j.biopha.2021.112008_bib20","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jsps.2018.01.005","article-title":"Ocular administration of acetazolamide microsponges in situ gel formulations","volume":"26","author":"Obiedallah","year":"2018","journal-title":"Saudi Pharm. J."},{"issue":"5","key":"10.1016\/j.biopha.2021.112008_bib21","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1111\/jphp.13239","article-title":"Reduction of intraocular pressure using timolol orally dissolving strips in the treatment of induced primary open-angle glaucoma in rabbits","volume":"72","author":"El-Feky","year":"2020","journal-title":"J. Pharm. Pharmacol."},{"issue":"1","key":"10.1016\/j.biopha.2021.112008_bib22","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1080\/10717544.2018.1477861","article-title":"Sustained ocular delivery of Dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits","volume":"25","author":"Fouda","year":"2018","journal-title":"Drug Deliv."},{"issue":"11","key":"10.1016\/j.biopha.2021.112008_bib23","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.3109\/03639041003801885","article-title":"Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery","volume":"36","author":"Ammar","year":"2010","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.biopha.2021.112008_bib24","series-title":"Bancroft\u2019s Theory and Practice of Histological Techniques","author":"Suvarna","year":"2019"},{"issue":"3","key":"10.1016\/j.biopha.2021.112008_bib25","doi-asserted-by":"crossref","first-page":"203","DOI":"10.11613\/BM.2011.029","article-title":"Multiple comparison analysis testing in ANOVA","volume":"21","author":"Mc Hugh","year":"2011","journal-title":"Biochem. Med."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.112008_bib26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijpharm.2010.05.012","article-title":"Effect of DMSO on micellization, gelation \u20ac and drug release profile of Poloxamer 407","volume":"394","author":"Ur-Rehman","year":"2010","journal-title":"Int J. Pharm."},{"key":"10.1016\/j.biopha.2021.112008_bib27","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.carbpol.2016.08.073","article-title":"A novel pH-induced thermosensitive hydrogel composed of carboxymethyl chitosan and poloxamer cross-linked by glutaraldehyde for ophthalmic drug delivery","volume":"155","author":"Yu","year":"2017","journal-title":"Carbohydr. Polym."},{"issue":"2","key":"10.1016\/j.biopha.2021.112008_bib28","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ejpb.2010.02.011","article-title":"A poloxamer\/chitosan in situ forming gel with prolonged retention time for ocular delivery","volume":"75","author":"Gratieri","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"5","key":"10.1016\/j.biopha.2021.112008_bib29","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1016\/j.xphs.2020.01.021","article-title":"Elucidation of colloid performances of thermosensitive in situ\u2013forming ophthalmic gel formed by poloxamer 407 for loading drugs","volume":"109","author":"Jiang","year":"2020","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.biopha.2021.112008_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.ejpb.2017.01.008","article-title":"Poloxamer-based thermoresponsive ketorolac tromethamine in situ gel preparations: Design, characterisation, toxicity and transcorneal permeation studies","volume":"114","author":"Fathalla","year":"2017","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"2","key":"10.1016\/j.biopha.2021.112008_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172306","article-title":"Development of topical ophthalmic In Situ gel-forming estradiol delivery system intended for the prevention of age-related cataracts","volume":"12","author":"Kotreka","year":"2017","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.biopha.2021.112008_bib32","doi-asserted-by":"crossref","first-page":"859","DOI":"10.3390\/pharmaceutics12090859","article-title":"Recent advances in the development of in situ gelling drug delivery systems for non-parenteral administration routes","volume":"12","author":"Vigani","year":"2020","journal-title":"Pharmaceutics"},{"issue":"1","key":"10.1016\/j.biopha.2021.112008_bib33","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.intimp.2013.05.020","article-title":"Preparation and evaluation of sinomenine hydrochloride in situ gel for uveitis treatment","volume":"17","author":"Song","year":"2013","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2021.112008_bib34","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1007\/s12247-018-9335-z","article-title":"Hydrogel containing peg-coated fluconazole nanoparticles with enhanced solubility and antifungal activity","volume":"14","author":"Abdellatif","year":"2019","journal-title":"J. Pharm. Innov."},{"issue":"8","key":"10.1016\/j.biopha.2021.112008_bib35","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.jsps.2020.07.001","article-title":"Thermoresponsive sol-gel improves ocular bioavailability of dipivefrin hydrochloride and potentially reduces the elevated intraocular pressure in vivo","volume":"28","author":"Alkholief","year":"2020","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.biopha.2021.112008_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0248857","article-title":"Experimental design, formulation and in vivo evaluation of a novel topical in situ gel system to treat ocular infections","volume":"16","author":"Nair","year":"2021","journal-title":"PLOS One"},{"key":"10.1016\/j.biopha.2021.112008_bib37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jddst.2019.01.025","article-title":"In-situ gel of nifedipine for preeclampsia: optimization, in-vitro and in-vivo evaluation","volume":"50","author":"Karemore","year":"2019","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"4","key":"10.1016\/j.biopha.2021.112008_bib38","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1002\/app.28163","article-title":"In situ gel forming systems of poloxamer 407 and hydroxypropyl cellulose or hydroxypropyl methyl cellulose mixtures for controlled delivery of vancomycin","volume":"109","author":"Talasaz","year":"2008","journal-title":"J. Appl. Polym. Sci."},{"issue":"105","key":"10.1016\/j.biopha.2021.112008_bib39","first-page":"1","article-title":"In-vitro and in-vivo evaluation of niosomal gel containing aceclofenac for sustained drug delivery","volume":"1","author":"Fathalla","year":"2014","journal-title":"Int J. Pharm. Sci. Res."},{"key":"10.1016\/j.biopha.2021.112008_bib40","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ejps.2015.05.014","article-title":"Novel thermosensitive in situ gel based on poloxamer for uterus delivery","volume":"77","author":"Lu","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"issue":"1\u20132","key":"10.1016\/j.biopha.2021.112008_bib41","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ijpharm.2012.03.054","article-title":"Thermosensitive and mucoadhesive in situ gel based on poloxamer as new carrier for rectal administration of nimesulide","volume":"430","author":"Yuan","year":"2012","journal-title":"Int J. Pharm."},{"issue":"8","key":"10.1016\/j.biopha.2021.112008_bib42","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/j.drudis.2019.05.036","article-title":"Poloxamer-based in situ gelling thermoresponsive systems for ocular drug delivery applications","volume":"24","author":"Soliman","year":"2019","journal-title":"Drug Discov. Today"},{"issue":"3","key":"10.1016\/j.biopha.2021.112008_bib43","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0149-2918(01)80048-5","article-title":"Efficacy and tolerability of timolol maleate ophthalmic gel-forming solution versus timolol ophthalmic solution in adults with open-angle glaucoma or ocular hypertension: a six-month, double-masked, multicenter study","volume":"23","author":"Shedden","year":"2001","journal-title":"Clin. Ther."},{"key":"10.1016\/j.biopha.2021.112008_bib44","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ejps.2017.04.013","article-title":"Nanoemulsion-based electrolyte triggered in situ gel for ocular delivery of acetazolamide","volume":"104","author":"Morsi","year":"2017","journal-title":"Eur. J. Pharm. Sci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221007915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332221007915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:27:58Z","timestamp":1760099278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332221007915"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":44,"alternative-id":["S0753332221007915"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112008","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repurposing of nifedipine loaded in situ ophthalmic gel as a novel approach for glaucoma treatment","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2021.112008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"112008"}}